N/A
N=562
Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer
Cancer
Bottom Line
View on ClinicalTrials.gov: NCT05590962 ↗Enrolled (actual)
562
Serious AEs
0.0%
Results posted
Feb 2025
Primary outcome: Primary: Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of Enrollment — 22; 130 participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- EHR Nudge (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Primary completion
- Jun 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of Enrollment |
22; 130 | — |
Summary
Patients with advanced cancer suffer from high symptom burden and aggressive end-of-life care. Early specialty palliative care is an evidence-based practice that improves symptom burden, quality of life, and survival in advanced cancer. However, over half of patients with advanced cancer die before receiving palliative care. Clinician-level biases and suboptimal identification of high-risk patients are major barriers to palliative care uptake. In this 2-arm pragmatic clinical trial, the investigators will randomize practices within a large community oncology network to receive an intervention consisting of algorithm-based default palliative care referrals. The investigators will study the impact of such an intervention on palliative care utilization and end-of-life outcomes.
Eligibility Criteria
Inclusion Criteria
Patients:
- Stage III and IV lung, and non-Colorectal GI cancers, defined using internal algorithms based on International Classification of Diseases (ICD) diagnosis codes, EHR entries, and manual screening
Exclusion Criteria
Patients:
- Benign hematology, genetics, survivorship encounters; no prior EHR data;
- Deceased or enrolled in hospice care
- Had a palliative care visit or had no medical oncology visit within the prior 90 days or are seen for a non-medical oncology encounter
Data sourced from ClinicalTrials.gov (NCT05590962). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.